These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15996222)

  • 1. PELD: working well, but only half of the time?
    Magee JC; Feng S
    Am J Transplant; 2005 Aug; 5(8):1785-6. PubMed ID: 15996222
    [No Abstract]   [Full Text] [Related]  

  • 2. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
    Shneider BL; Suchy FJ; Emre S
    Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The donor liver allocation system: a model for end-stage liver disease.
    Wu J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):330-1. PubMed ID: 15313662
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving liver allocation: MELD and PELD.
    Freeman RB; Wiesner RH; Roberts JP; McDiarmid S; Dykstra DM; Merion RM
    Am J Transplant; 2004; 4 Suppl 9():114-31. PubMed ID: 15113360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of PELD on OPTN liver allocation: preliminary results.
    Davies DB
    Clin Transpl; 2003; ():13-20. PubMed ID: 15387095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based evolution of the MELD/PELD liver allocation policy.
    Wiesner RH
    Liver Transpl; 2005 Mar; 11(3):261-3. PubMed ID: 15719393
    [No Abstract]   [Full Text] [Related]  

  • 7. Mortality risk, behavior, and pediatric liver allocation.
    Freeman RB
    Liver Transpl; 2006 Jan; 12(1):12-5. PubMed ID: 16382452
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver allocation: the intent-to-treat approach.
    Freeman RB
    Transpl Int; 2006 Apr; 19(4):270-4. PubMed ID: 16573541
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of MELD on OPTN liver allocation: preliminary results.
    Edwards EB; Harper AM
    Clin Transpl; 2002; ():21-8. PubMed ID: 12971434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we change the priority for liver allocation for patients with the highest MELD score?
    Freeman RB; Wiesner R
    Hepatology; 2012 Jan; 55(1):14-5. PubMed ID: 22095707
    [No Abstract]   [Full Text] [Related]  

  • 11. MELD-based allocation scheme for liver transplantation in Israel.
    Onaca N; Mor E
    Isr Med Assoc J; 2006 Sep; 8(9):651-2. PubMed ID: 17058421
    [No Abstract]   [Full Text] [Related]  

  • 12. Model for end-stage liver disease exceptions: proceed with caution.
    Washburn K
    Liver Transpl; 2011 Oct; 17(10):1123-4. PubMed ID: 21837739
    [No Abstract]   [Full Text] [Related]  

  • 13. In a MELD-based economy, how can we fight off inflation?
    Biggins SW; Feng S
    Liver Transpl; 2007 Jan; 13(1):2-4. PubMed ID: 17192889
    [No Abstract]   [Full Text] [Related]  

  • 14. PELD allocation and acute liver/graft failure.
    Sindhi R; Soltys K; Bond G; Marcos A; Mazariegos G
    Liver Transpl; 2007 May; 13(5):776-7. PubMed ID: 17457898
    [No Abstract]   [Full Text] [Related]  

  • 15. MELD--an imperfect, but thus far the best, solution to the problem of organ allocation.
    Lake JR
    J Gastrointestin Liver Dis; 2008 Mar; 17(1):5-7. PubMed ID: 18392236
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience.
    Shneider BL; Neimark E; Frankenberg T; Arnott L; Suchy FJ; Emre S
    Liver Transpl; 2005 Jul; 11(7):788-795. PubMed ID: 15973720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a pediatric end-stage liver disease score for deceased donor allocation: the United States experience.
    McDiarmid SV; Merion RM; Dykstra DM; Harper AM
    Indian J Pediatr; 2007 Apr; 74(4):387-92. PubMed ID: 17476086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for end-stage liver disease (MELD) exception guidelines.
    Wiesner R; Lake JR; Freeman RB; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S85-7. PubMed ID: 17123285
    [No Abstract]   [Full Text] [Related]  

  • 19. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation in Hawaii.
    Wong LL; Cheung AH; Limm WM; Tsai NC
    Hawaii Med J; 1994 Mar; 53(3):86-9. PubMed ID: 8005783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.